Spero Therapeutics, Inc. SPRO
1.04 USD 0.00 (+0.00%)
At closeNov 3, 2026, 7:33 PM EST
1.05 +0.01 +0.96%
After hours · Nov 3, 7:33 PM ET
1.03 Day range 1.06
1.03 52-week range 3.08
- YTD
- -55.36%
- 1 year
- -56.30%
Analyst view
Consensus: buy
Buy
Price target (mean) 5.00
Ratings (0m) 4 2 buy · 2 hold · 0 sell
- Strong buy1
- Buy1
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.40667 | -0.60 – -0.27 | 0.96 | -142.4% | 4.13M | -94.4% | 3 |
| Next quarter | -0.265 | -0.33 – -0.20 | -0.24 | -10.4% | 11.00M | +18.7% | 2 |
| Current year | -1.29 | -1.48 – -1.17 | 0.5305 | -343.8% | 36.94M | -64.4% | 3 |
| Next year | -0.91667 | -1.17 – -0.74 | -1.29 | +29.1% | 20.00M | -45.9% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Dec 2, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 18, 2024 | TD Cowen | Downgrade | Buy | Hold |
| Nov 15, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Nov 4, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 6, 2024 | TD Cowen | Upgrade | Hold | Buy |
| Aug 6, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Aug 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 4, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Mar 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 5, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 1, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 20, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Sep 26, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Sep 23, 2022 | Evercore ISI Group | Upgrade | In-Line | Outperform |
| Aug 15, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 23, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 20, 2022 | Berenberg | Downgrade | Buy | Hold |
| May 17, 2022 | Cantor Fitzgerald | Maintained | — | Overweight |
| May 4, 2022 | Cowen & Co. | Downgrade | Outperform | Market Perform |
| May 4, 2022 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Apr 18, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 21, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 1, 2021 | Oppenheimer | Downgrade | Outperform | Perform |
| Jan 22, 2021 | HC Wainwright & Co. | Maintained | — | Buy |